Complement anaphylatoxins as immune regulators in cancer

Eli T. Sayegh, Orin Bloch, Andrew T. Parsa

Research output: Contribution to journalReview article

23 Citations (Scopus)

Abstract

The role of the complement system in innate immunity is well characterized. However, a recent body of research implicates the complement anaphylatoxins C3a and C5a as insidious propagators of tumor growth and progression. It is now recognized that certain tumors elaborate C3a and C5a and that complement, as a mediator of chronic inflammation and regulator of immune function, may in fact foster rather than defend against tumor growth. A putative mechanism for this function is complement-mediated suppression of immune effector cells responsible for immunosurveillance within the tumor microenvironment. This paradigm accords with models of immune dysregulation, such as autoimmunity and infectious disease, which have defined a pathophysiological role for abnormal complement signaling. Several types of immune cells express the cognate receptors for the complement anaphylatoxins, C3aR and C5aR, and demonstrate functional modulation in response to complement stimulation. In turn, impairment of antitumor immunity has been intimately tied to tumor progression in animal models of cancer. In this article, the literature was systematically reviewed to identify studies that have characterized the effects of the complement anaphylatoxins on the composition and function of immune cells within the tumor microenvironment. The search identified six studies based upon models of lymphoma and ovarian, cervical, lung, breast, and mammary cancer, which collectively support the paradigm of complement as an immune regulator in the tumor microenvironment.

Original languageEnglish (US)
Pages (from-to)747-758
Number of pages12
JournalCancer Medicine
Volume3
Issue number4
DOIs
StatePublished - Aug 2014
Externally publishedYes

Fingerprint

Anaphylatoxins
Tumor Microenvironment
Complement C3a
Complement C5a
Neoplasms
Breast Neoplasms
Immunologic Monitoring
Complement Receptors
Inflammation Mediators
Growth
Autoimmunity
Innate Immunity
Uterine Cervical Neoplasms
Ovarian Neoplasms
Communicable Diseases
Immunity
Lymphoma
Lung Neoplasms
Animal Models
Research

Keywords

  • Anaphylatoxins
  • Cancer
  • Complement
  • Immune
  • Microenvironment

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Complement anaphylatoxins as immune regulators in cancer. / Sayegh, Eli T.; Bloch, Orin; Parsa, Andrew T.

In: Cancer Medicine, Vol. 3, No. 4, 08.2014, p. 747-758.

Research output: Contribution to journalReview article

Sayegh, Eli T. ; Bloch, Orin ; Parsa, Andrew T. / Complement anaphylatoxins as immune regulators in cancer. In: Cancer Medicine. 2014 ; Vol. 3, No. 4. pp. 747-758.
@article{e980562b99724e4ab75086bd424b5f18,
title = "Complement anaphylatoxins as immune regulators in cancer",
abstract = "The role of the complement system in innate immunity is well characterized. However, a recent body of research implicates the complement anaphylatoxins C3a and C5a as insidious propagators of tumor growth and progression. It is now recognized that certain tumors elaborate C3a and C5a and that complement, as a mediator of chronic inflammation and regulator of immune function, may in fact foster rather than defend against tumor growth. A putative mechanism for this function is complement-mediated suppression of immune effector cells responsible for immunosurveillance within the tumor microenvironment. This paradigm accords with models of immune dysregulation, such as autoimmunity and infectious disease, which have defined a pathophysiological role for abnormal complement signaling. Several types of immune cells express the cognate receptors for the complement anaphylatoxins, C3aR and C5aR, and demonstrate functional modulation in response to complement stimulation. In turn, impairment of antitumor immunity has been intimately tied to tumor progression in animal models of cancer. In this article, the literature was systematically reviewed to identify studies that have characterized the effects of the complement anaphylatoxins on the composition and function of immune cells within the tumor microenvironment. The search identified six studies based upon models of lymphoma and ovarian, cervical, lung, breast, and mammary cancer, which collectively support the paradigm of complement as an immune regulator in the tumor microenvironment.",
keywords = "Anaphylatoxins, Cancer, Complement, Immune, Microenvironment",
author = "Sayegh, {Eli T.} and Orin Bloch and Parsa, {Andrew T.}",
year = "2014",
month = "8",
doi = "10.1002/cam4.241",
language = "English (US)",
volume = "3",
pages = "747--758",
journal = "Cancer Medicine",
issn = "2045-7634",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Complement anaphylatoxins as immune regulators in cancer

AU - Sayegh, Eli T.

AU - Bloch, Orin

AU - Parsa, Andrew T.

PY - 2014/8

Y1 - 2014/8

N2 - The role of the complement system in innate immunity is well characterized. However, a recent body of research implicates the complement anaphylatoxins C3a and C5a as insidious propagators of tumor growth and progression. It is now recognized that certain tumors elaborate C3a and C5a and that complement, as a mediator of chronic inflammation and regulator of immune function, may in fact foster rather than defend against tumor growth. A putative mechanism for this function is complement-mediated suppression of immune effector cells responsible for immunosurveillance within the tumor microenvironment. This paradigm accords with models of immune dysregulation, such as autoimmunity and infectious disease, which have defined a pathophysiological role for abnormal complement signaling. Several types of immune cells express the cognate receptors for the complement anaphylatoxins, C3aR and C5aR, and demonstrate functional modulation in response to complement stimulation. In turn, impairment of antitumor immunity has been intimately tied to tumor progression in animal models of cancer. In this article, the literature was systematically reviewed to identify studies that have characterized the effects of the complement anaphylatoxins on the composition and function of immune cells within the tumor microenvironment. The search identified six studies based upon models of lymphoma and ovarian, cervical, lung, breast, and mammary cancer, which collectively support the paradigm of complement as an immune regulator in the tumor microenvironment.

AB - The role of the complement system in innate immunity is well characterized. However, a recent body of research implicates the complement anaphylatoxins C3a and C5a as insidious propagators of tumor growth and progression. It is now recognized that certain tumors elaborate C3a and C5a and that complement, as a mediator of chronic inflammation and regulator of immune function, may in fact foster rather than defend against tumor growth. A putative mechanism for this function is complement-mediated suppression of immune effector cells responsible for immunosurveillance within the tumor microenvironment. This paradigm accords with models of immune dysregulation, such as autoimmunity and infectious disease, which have defined a pathophysiological role for abnormal complement signaling. Several types of immune cells express the cognate receptors for the complement anaphylatoxins, C3aR and C5aR, and demonstrate functional modulation in response to complement stimulation. In turn, impairment of antitumor immunity has been intimately tied to tumor progression in animal models of cancer. In this article, the literature was systematically reviewed to identify studies that have characterized the effects of the complement anaphylatoxins on the composition and function of immune cells within the tumor microenvironment. The search identified six studies based upon models of lymphoma and ovarian, cervical, lung, breast, and mammary cancer, which collectively support the paradigm of complement as an immune regulator in the tumor microenvironment.

KW - Anaphylatoxins

KW - Cancer

KW - Complement

KW - Immune

KW - Microenvironment

UR - http://www.scopus.com/inward/record.url?scp=84916231498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84916231498&partnerID=8YFLogxK

U2 - 10.1002/cam4.241

DO - 10.1002/cam4.241

M3 - Review article

C2 - 24711204

AN - SCOPUS:84916231498

VL - 3

SP - 747

EP - 758

JO - Cancer Medicine

JF - Cancer Medicine

SN - 2045-7634

IS - 4

ER -